18 results
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
treatment and prevention ... - Comparison Table ... Anticoagulants #Anticoagulation ... #VTE #Management ... #Pharmacology #
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... Treatment #COVID19 #Pharmacology ... #Table #Management
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage

The table summarizes the recommendations for adult patients on
Hemorrhage The table ... Antithrombotics #Anticoagulation ... IntracranialHemorrhage #ICH #Management ... #Pharmacology # ... Table
A summary of the pharmacologic management of acute bleeding and secondary prevention of bleeds in LVAD
summary of the pharmacologic ... management of acute ... Anti-secretory Agents ... Thalidomide Danazol Anticoagulation ... #Management #Treatment
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
anti-parasitic agent ... here is a quick overview ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... Pain Management ... steroids, on ASA/anticoagulation ... • Neuropathic agents ... #agents #internship
Evans Syndrome Pharmacology Management 
Corticosteroids
IVIg
Rituximab
Splenectomy
Azathioprine
Cyclophosphamide
Cyclosporin
Mycophenolate
Vinka-alkaloid
Plasma exchange
Transfusion
Anticoagulation
Bone marrow stimulating agents

doi:10.3390/jcm9123851

#Evans #Syndrome #Pharmacology #Management #Medications #comparison #table
Evans Syndrome Pharmacology ... Management Corticosteroids ... exchange Transfusion Anticoagulation ... marrow stimulating agents ... #comparison #table
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
Recommendations for Preventing ... Microsporidiosis in HIV-AIDS Preventing ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
Recommendations for Preventing ... anti-diarrheal agent ... Trial of these agents ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology